Search - tctmd.com

Displaying 541 - 560 of 623

Sort: Relevancy | Date

News Industry News

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

July 14, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

January 22, 2014

Presentation

Role of Drug Coated Balloons in Acute Coronary Syndrome

Presenter: Bruno Scheller

December 02, 2013

Presentation

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Presenter: Bruno Scheller

December 01, 2013

Presentation TCT 2013

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Presenter: Michael Conte

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Advertisement

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Left Main Restenosis: Incidence, Implications, and Management

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

Role of Drug Coated Balloons in Acute Coronary Syndrome

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content